NCT04073576 is a NA clinical trial of AHCL in Type1diabetes, sponsored by Christchurch Clinical Studies Trust Ltd.

Who is sponsoring NCT04073576?

NCT04073576 is sponsored by Christchurch Clinical Studies Trust Ltd.

What drugs are being tested in NCT04073576?

Interventions in NCT04073576: AHCL, SAP+PLGM.

What condition does NCT04073576 study?

NCT04073576 studies Type1diabetes.

Is NCT04073576 still recruiting?

NCT04073576 is currently status unknown. Last updated 29 August 2019.

Last reviewed 2019-08-29 · How we verify

NCT04073576

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Two Insulin Pump Insulin Delivery Systems in Type 1 Diabetes.

Status unknown NA Last updated 29 August 2019

What this trial tests

NA trial testing AHCL in Type1diabetes in 60 participants. Status unknown.

Timeline

20 May 2019

Primary endpoint
11 October 2019

11 October 2019

Quick facts

Lead sponsor	Christchurch Clinical Studies Trust Ltd
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	20 May 2019
Primary completion	11 October 2019
Estimated completion	11 October 2019
Sites	1 location across New Zealand

Drugs / interventions tested

AHCL
SAP+PLGM

Conditions studied

Type1diabetes — all drugs for Type1diabetes →

Sponsor

Christchurch Clinical Studies Trust Ltd

Who can join

Adults 7 to 80, any sex, with Type1diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a study of the Minimed 670G 4.0 insulin pump, assessing the efficacy of the Advanced Hybrid Closed Loop (AHCL) algorithm in controlling blood glucose levels in Type 1 Diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of AHCL

Trials testing the same drug.

NCT06947031 — Efficacy and Safety of the Minimed 780G® Advanced Hybrid Closed Loop System (AHCL) in Patients With Type 1 Diabetes Unde · completed
NCT04235504 — ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes · NA · completed

Other recruiting trials for Type1diabetes

Currently open trials in the same condition.

NCT07139808 — Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System · NA · recruiting
NCT07092761 — Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System · NA · recruiting
NCT06646107 — Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There · recruiting
NCT06753994 — Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors · Phase 1 · recruiting
NCT05668507 — REACHOUT Mental Health Support Mobile App · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04073576 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Christchurch Clinical Studies Trust Ltd
Last refreshed: 29 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04073576.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing